Schedule 13D ownership disclosure

Aegerion Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 00767E102

Event date: 2015-01-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,637,455
Percent of class
5.7600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-15-000172
Form type
SC 13D
Filer
Aegerion Pharmaceuticals, Inc.
CIK
CIK 1338042
Filed
Feb 05, 2015
Reporting period
Jan 30, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub